Profile: Profectus BioSciences, Inc. is a research & development company that focuses on harnessing the immune system to treat & prevent viral diseases and cancers through the delivery of prime/boost vaccines & small molecules. We offer vaccines for the treatment and prevention of chronic viral diseases. We also develop multi-pronged method to identify small molecule inhibitors of NFkB thereby inhibiting p65 signaling, which activates many genes associated with the immune system. Our Profectus pDNA vaccine platform is substantially enhanced by the incorporation of the molecular adjuvants such as interleukin-12 (IL-12), which is delivered via electroporation, and formulated with bupivicaine, a stabilizing & transfection enhancing agent.